Volume 31, Issue 4 (Avicenna Journal of Clinical Medicine-Winter 2025)
Avicenna J Clin Med 2025, 31(4): 213-218 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aali H, Ghafari M, Pour Masomi H, Sofi D, Sanchol M, Forghani S A. Investigating the Relationship between COPD Severity and Inflammatory Markers ESRe and CRP in Hospitalized Patients. Avicenna J Clin Med 2025; 31 (4) :213-218
URL: http://sjh.umsha.ac.ir/article-1-3144-en.html
URL: http://sjh.umsha.ac.ir/article-1-3144-en.html
Halimeh Aali1 
, Mehrangiz Ghafari2 , Hossein Pour Masomi1 , Dadkhoda Sofi3 , Mohammad Sanchol4 , Seyed Ali Forghani4
, Mehrangiz Ghafari2 , Hossein Pour Masomi1 , Dadkhoda Sofi3 , Mohammad Sanchol4 , Seyed Ali Forghani4
1- Department of Internal Medicine, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran
2- Department of Pathology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran
3- Department of Internal Medicine, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran ,d_sofi@zbmu.ac.ir
4- Student Research Committee, Zabol University of Medical Sciences, Zabol, Iran
2- Department of Pathology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran
3- Department of Internal Medicine, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran ,
4- Student Research Committee, Zabol University of Medical Sciences, Zabol, Iran
Abstract: (623 Views)
Background and Objective: Chronic Obstructive Pulmonary Disease (COPD) is a type of obstructive pulmonary disease that is identified by chronic narrowing of the airways. This disease worsens over time, and the main symptoms of this disease include shortness of breath, cough, and phlegm. The purpose of this study was to determine the relationship between COPD disease severity and inflammatory markers erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in hospitalized patients.
Materials and Methods: After the admission of patients diagnosed with COPD into this descriptive-analytical study, a complete medical history was taken during their hospitalization. Necessary variables were collected, including current or previous cigarette or opium use and duration of exposure to fossil fuels. Especially in those who cook at home, ESR and CRP samples were taken from them in addition to routine tests, and the length of hospital stay was recorded in addition to common treatments. After collecting the data, they were recorded in SPSS V22 software and analyzed using descriptive statistics (prevalence, mean, and standard deviation) and using the Chi-square, Fisher's exact, independent t, and Mann-Whitney tests. The area under the receiver operating characteristic curve was used to determine the accuracy of the prediction of inflammatory markers in the outcome and severity of the disease. The significance level was considered less than 0.05.
Results: In this study, it was observed that the average scores of ESR and CRP of people with COPD were 54.68 and 1.50, respectively. The average ESR was 26.46 in people with mild COPD, 54.60 in people with moderate COPD, and 110.62 in people with severe COPD, and this difference was statistically significant (P=0.0001). The average CRP was 0.61 in people with mild COPD, 1.75 in people with moderate COPD, and 2.86 in people with severe COPD, which was statistically significant (P=0.0001).
Conclusion: The results of this study showed that there was a significant relationship between ESR and CRP with the outcome of COPD, and a significant relationship was observed between ESR and CRP and the severity of COPD disease.
Materials and Methods: After the admission of patients diagnosed with COPD into this descriptive-analytical study, a complete medical history was taken during their hospitalization. Necessary variables were collected, including current or previous cigarette or opium use and duration of exposure to fossil fuels. Especially in those who cook at home, ESR and CRP samples were taken from them in addition to routine tests, and the length of hospital stay was recorded in addition to common treatments. After collecting the data, they were recorded in SPSS V22 software and analyzed using descriptive statistics (prevalence, mean, and standard deviation) and using the Chi-square, Fisher's exact, independent t, and Mann-Whitney tests. The area under the receiver operating characteristic curve was used to determine the accuracy of the prediction of inflammatory markers in the outcome and severity of the disease. The significance level was considered less than 0.05.
Results: In this study, it was observed that the average scores of ESR and CRP of people with COPD were 54.68 and 1.50, respectively. The average ESR was 26.46 in people with mild COPD, 54.60 in people with moderate COPD, and 110.62 in people with severe COPD, and this difference was statistically significant (P=0.0001). The average CRP was 0.61 in people with mild COPD, 1.75 in people with moderate COPD, and 2.86 in people with severe COPD, which was statistically significant (P=0.0001).
Conclusion: The results of this study showed that there was a significant relationship between ESR and CRP with the outcome of COPD, and a significant relationship was observed between ESR and CRP and the severity of COPD disease.
Type of Study: Original |
Subject:
Lung Diseases
Extended Abstract [HTM 31 KB] (47 Download)
References
1. Saghafi Khadem S, Sookhtanloo M, Zeidabadi F, Javan Rashid A. Evaluation of High-Sensitivity C-Reactive Protein and Irisin in Saliva and Serum of Patients with Myocardial Infarction. J Mashhad Dental School. 2023;47(2):135-46. DOI: 10.22038/jmds.2023.62712.2134
2. Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019;14:343-352. PMID: 30863037 DOI: 10.2147/COPD.S184653
3. Melzer AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, McBurnie MA, Mularski RA, et al. Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respir Med. 2017;123:124-30. PMID: 28137488 DOI: 10.1016/j.rmed.2016.12.011
4. Maricoto T, Santos D, Carvalho C, Teles I, Correia-de-Sousa J, Taborda-Barata L. Assessment of poor inhaler technique in older patients with asthma or COPD: a predictive tool for clinical risk and inhaler performance. Drugs & Aging. 2020;37:605-616. PMID: 32602039 DOI: 10.1007/s40266-020-00779-6
5. Hioki H, Watanabe Y, Kozuma K, Yamamoto M, Naganuma T, Araki M, et al. Effect of serum C-reactive protein level on admission to predict mortality after transcatheter aortic valve implantation. Am J Cardiol. 2018;122(2):294-301. PMID: 29735216 DOI: 10.1016/j.amjcard.2018.04.005
6. Bhattarai A, Shakya R, Bista D. Impact of Pharmacist-Led Intervention on Adherence to Inhalers, Inhalation Technique, and Disease Control Among Asthma/COPD Patients in a Resource Limited Center: An Interventional Study. Patient Prefer Adherence. 2024;18:1395-1408. PMID: 38974680 DOI: 10.2147/PPA.S460810
7. Wen W-H, Cheng M-H, Lee K-C, Lin P-C. Rate of Correct Inhaler Usage and Related Factors in Elderly Patients With Chronic Obstructive Pulmonary Disease. Hu Li Za Zhi. 2024;71(3):43-51. PMID: 38817136 DOI: 10.6224/JN.202406_71(3).07
8. Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V, Incalzi RA. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD). Arch gerontol geriatri. 2011;53(2):190-195. PMID: 21074870 DOI: 10.1016/j.archger.2010.10.015
9. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006;61(1):17-22. PMID: 16055618 DOI: 10.1136/thx.2005.041996
10. Silva DR, Gazzana MB, Knorst MM. C-reactive protein levels in stable COPD patients: a case-control study. Int J Chron Obstruct Pulmon Dis. 2015;10:1719-1725. PMID: 26357470 DOI: 10.2147/COPD.S87015
11. Eagan T, Ueland T, Wagner P, Hardie J, Mollnes T, Damås J, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010;35(3):540-548. PMID: 19643942 DOI: 10.1183/09031936.00088209
12. Kanwal A, Bashir A, Gohier A, Habib B. Association of red blood cell indices and erythrocyte sedimentation rate in chronic obstructive pulmonary disease (copd) patients. Pakistan Armed Forces Med J. 2021;71(2):610-613. Link
13. Fattouh M, Alkady O. Inflammatory biomarkers in chronic obstructive pulmonary disease. Egyptian J Chest Dis Tuberculosis. 2014;63(4):799-804.
14. Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2017;26(143). PMID: 28143876 DOI: 10.1183/16000617.0070-2016
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
